However, it is fascinating to note that NQO1 expression levels are significantly low in metastatic tissues derived from multiple sites of prostate cancer patients suggesting a possible gatekeeper role against metastasis (Fig. 2a). Here, NQO1 is linked to prostate carcinoma.